Pfizer Accused of Hiding Contraceptive’s Brain Tumor Link (1)

Nov. 5, 2024, 8:44 PM UTCUpdated: Nov. 5, 2024, 9:05 PM UTC

Pfizer Inc. failed to warn patients that its injectable contraceptive drug Depo-Provera can increase the risk of developing brain tumors, a new lawsuit alleged.

“For several decades the manufacturers and sellers of Depo-Provera and its authorized generic and generic analogues” had a responsibility to investigate whether the medication could contribute to the growth of brain tumors, according to the complaint filed Monday in the US District Court for the Central District of California.

Plaintiff Taylor Devorak alleged that researchers have found Depo-Provera and similar progesterone medications have been linked to a greater incidence of brain tumors called intracranial meningioma. She’s ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.